Literature DB >> 22307599

Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.

Xuan Cao1, Courtney Voss, Bing Zhao, Tomonori Kaneko, Shawn Shun-Cheng Li.   

Abstract

The epithelial growth factor receptor plays an important role in cell migration and cancer metastasis, but the underlying molecular mechanism is not fully understood. We show here that differential regulation of the Ras-homology-GTPase-activating protein [corrected] (Rho-GAP) activity of deleted in liver cancer 1 (DLC1) by tensin3 and COOH-terminal tensin-like protein (cten) controls EGF-driven cell migration and transformation. Tensin3 binds DLC1 through its actin-binding domain, a region that is missing in cten, and thereby releases an autoinhibitory interaction between the sterile alpha motif and Rho-GAP domains of DLC1. Consequently, tensin3, but not cten, promotes the activation of DLC1, which, in turn, leads to inactivation of RhoA and decreased cell migration. Depletion of endogenous tensin3, but not cten, augmented the formation of actin stress fibers and focal adhesions and enhanced cell motility. These effects were, however, ablated by an inhibitor of the Rho-associated protein kinase. Importantly, activation of DLC1 by tensin3 or its actin-binding domain drastically reduced the anchorage-independent growth of transformed cells. Our study therefore links dynamic regulation of tensin family members by EGF to Rho-GAP through DLC1 and suggests that the tensin-DLC1-RhoA signaling axis plays an important role in tumorigenesis and cancer metastasis, and may be explored for cancer intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307599      PMCID: PMC3277110          DOI: 10.1073/pnas.1114368109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 2.  Rho GTPase-activating proteins in cell regulation.

Authors:  Sun Young Moon; Yi Zheng
Journal:  Trends Cell Biol       Date:  2003-01       Impact factor: 20.808

Review 3.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 4.  Tensin.

Authors:  Su Hao Lo
Journal:  Int J Biochem Cell Biol       Date:  2004-01       Impact factor: 5.085

5.  Cten mRNA expression was correlated with tumor progression in lung cancers.

Authors:  Hidefumi Sasaki; Satoru Moriyama; Kotaro Mizuno; Haruhiro Yukiue; Akimitsu Konishi; Motoki Yano; Masahiro Kaji; Ichiro Fukai; Masanobu Kiriyama; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Lung Cancer       Date:  2003-05       Impact factor: 5.705

6.  Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.

Authors:  Bao-Zhu Yuan; Marian E Durkin; Nicholas C Popescu
Journal:  Cancer Genet Cytogenet       Date:  2003-01-15

7.  Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Authors:  Chun-Ming Wong; Joyce Man-Fong Lee; Yick-Pang Ching; Dong-Yan Jin; Irene Oi-lin Ng
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

8.  Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion.

Authors:  Emily H Hall; Abbi E Daugherty; Colin K Choi; Alan F Horwitz; David L Brautigan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

9.  Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.

Authors:  Wenle Xia; Robert J Mullin; Barry R Keith; Lei-Hua Liu; Hong Ma; David W Rusnak; Gary Owens; Krystal J Alligood; Neil L Spector
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

10.  Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.

Authors:  Su Hao Lo; Tung Bin Lo
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  34 in total

1.  Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.

Authors:  Lihong Chen; Changdong Liu; Frankie Chi Fat Ko; Naining Xu; Irene Oi-Lin Ng; Judy Wai Ping Yam; Guang Zhu
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  Tensin1 positively regulates RhoA activity through its interaction with DLC1.

Authors:  Yi-Ping Shih; Peng Sun; Aifeng Wang; Su Hao Lo
Journal:  Biochim Biophys Acta       Date:  2015-09-28

3.  Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.

Authors:  Yi-Ping Shih; Sarah Y Yuan; Su Hao Lo
Journal:  Cancer Lett       Date:  2017-04-10       Impact factor: 8.679

4.  Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.

Authors:  Xiaoling Zhou; Xu-Yu Yang; Nicholas C Popescu
Journal:  Biochem Biophys Res Commun       Date:  2012-03-07       Impact factor: 3.575

5.  Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS.

Authors:  Ehsan Amin; Mamta Jaiswal; Urszula Derewenda; Katarina Reis; Kazem Nouri; Katja T Koessmeier; Pontus Aspenström; Avril V Somlyo; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

Review 6.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

7.  Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.

Authors:  Udhayakumar Gopal; Yvonne Mowery; Kenneth Young; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2019-07-29       Impact factor: 5.157

8.  C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.

Authors:  Daine T Bennett; Thomas Brett Reece; Lisa S Foley; Ayla Sjoberg; Xianzhong Meng; David A Fullerton; Michael J Weyant
Journal:  J Thorac Cardiovasc Surg       Date:  2014-09-18       Impact factor: 5.209

9.  Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.

Authors:  Archna Ravi; Shelly Kaushik; Aarthi Ravichandran; Catherine Qiurong Pan; Boon Chuan Low
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

10.  DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.

Authors:  Rakesh Joshi; Lyugao Qin; Xuan Cao; Shanshan Zhong; Courtney Voss; Weiping Min; Shawn S C Li
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.